Extracorporeal Magnetotransduction Therapy (EMTT®) is a non-invasive, high-energy magnetic field therapy developed by STORZ Medical for the treatment of musculoskeletal, bone, and nerve disorders. It uses ultra-short, high-frequency electromagnetic pulses to induce biological effects at the cellular level.
Unlike traditional electromagnetic therapies like PEMF (Pulsed Electromagnetic Fields), EMTT achieves significantly higher oscillation frequencies (up to 300 kHz) and field strengths (up to 80–150 mT), enabling deep tissue penetration (up to 18 cm) and wide-ranging regenerative effects without thermal damage .
Uses ultra-short, high-frequency electromagnetic pulses up to 300 kHz to induce biological effects at the cellular level.
field strengths (up to 80–150 mT), enabling deep tissue penetration (up to 18 cm) and wide-ranging regenerative effects without thermal damage .
Unlike traditional electromagnetic therapies like PEMF (Pulsed Electromagnetic Fields), EMTT achieves significantly higher oscillation frequencies (up to 300 kHz)
EMTT is FDA-cleared and CE-certified, and delivered using the Magnetolith® device
EMTT uses a high-voltage generator to deliver ultra-short magnetic pulses at high frequencies ranging from 120–300 kHz. These nanosecond-scale bursts are emitted at a pulse repetition rate of approximately 3 Hz, creating a biologically active electromagnetic field that penetrates deeply, without generating heat.
EMTT uses high-energy, oscillating electromagnetic fields to stimulate cellular repair and regeneration. Its pulsed signal penetrates deep tissues non-invasively, activating bioelectrical healing pathways.
Restores normal membrane polarization and facilitates ion exchange, essential for cellular stability and healing.
Boosts oxidative phosphorylation (OxPhos) and Complex I activity, leading to increased ATP production, the energy currency needed for tissue regeneration and bone formation.
Stimulates expression of osteogenic and neurotrophic factors like Collagen I, BMP-2, VEGF, and Osteocalcin, supporting both structural and vascular repair.
Downregulates key pro-inflammatory mediators including IL-6, IL-8, and PGE2, helping resolve chronic inflammation at the root level.
Promotes mesenchymal stem cell activation, angiogenesis, and improved cellular signaling, accelerating recovery across soft tissue, bone, and nerve structures.
The electromagnetic field penetrates up to 18 cm deep, making it effective for treating deep tissue, bone, and nerve disorders.
The electromagnetic field does not produce heat, making EMTT safe and painless while biologically active and deeply effective.
While both EMTT and traditional PEMF use electromagnetic fields to influence healing, the differences in power, frequency, and tissue penetration make EMTT a far more advanced and clinically effective option
| Feature | PEMF | EMTT |
|---|---|---|
| Field Strength | 1–15 mT | 80–150 mT |
| Frequency | Low (1–100 Hz) | High (120–300 kHz) |
| Penetration Depth | 3–5 cm | Up to 18 cm |
| Waveform Type | Oscillating | Ultra-short pulsed bursts |
| FDA-Cleared for Bone Healin | Yes | Yes |
| Thermal Output | None | None |
| Delivery Device | Low-power pad | High-energy transducer (Magnetolith®) |
Research has shown it can
Stimulate bone-building cells (osteoblasts) to promote mineralization and structural repair
Recharge mitochondrial function, boosting ATP production for faster tissue recovery Accelerate repair of soft tissues, including fibroblasts (connective tissue) and chondrocytes (cartilage cells)
Accelerate repair of soft tissues, including fibroblasts (connective tissue) and chondrocytes (cartilage cells)
Reduce nerve hypersensitivity, calming pain signals at both the spinal and peripheral levels
Improve circulation and lymphatic flow, supporting waste removal and nutrient delivery
Support post-surgical healing and rehabilitation, restoring mobility and function more efficiently
Together, these effects make EMTT a powerful regenerative technology and a core component of The S.H.I.V.A. Method™, designed to go beyond symptom relief by activating deep cellular repair and promoting whole-system recovery from within.
Downregulated Processes
Upregulated ProcessesClinical studies, real-world outcomes, and peer-reviewed case reports have shown that EMTT offers a powerful, non-invasive solution for healing and recovery. Documented benefits include:
Significant pain relief without reliance on medications, injections, or invasive procedures
Enhanced joint mobility and tendon function, even in stubborn or degenerative cases
Accelerated bone healing, especially in cases of delayed union or non-union fractures
Shortened recovery timelines, helping patients return to work, activity, or sport faster
Breakthrough outcomes in patients who haven’t improved with standard physical therapy or rehabilitation methods
By targeting the root cellular and metabolic dysfunction behind many chronic pain conditions, EMTT unlocks healing potential where other treatments often fall short.
EMTT is clinically proven to support recovery across a wide range of musculoskeletal, neurological, and post-surgical conditions, especially when traditional treatments have plateaued. Commonly treated conditions include:
Spine & Back
Chronic low back pain and disc-related spine issues Cervical radiculopathy and neck nerve irritation Sciatica and radiating nerve pain from the lower back Tendinopathies, including Achilles tendon pain, Rotator cuff irritation, patellar tendinopathy
Tendons
Plantar fasciitis and heel pain
PAseptic osteitis pubis (chronic pelvic bone inflammation)
PDelayed bone healing and non-union fractures
PPost-surgical recovery from bone grafts and orthopedic repairs
Bone & Tissue
Myofascial pain syndrome and soft tissue tension
Joint degeneration such as hip or knee osteoarthritis
Enthesopathies, like tennis elbow (lateral epicondylitis)
Whether you’re recovering from injury, surgery, or dealing with long-standing joint or nerve pain, EMTT offers a deep cellular healing approach that goes beyond surface-level symptom relief.
In the S.H.I.V.A. Method™, EMTT is not just another tool it is a precisely integrated regenerative technology that enhances healing when used at the right time, with the right intent, and in synergy with other targeted interventions.
EMTT is carefully introduced into the system-based treatment plan once foundational imbalances have been addressed. We don’t just “use it”; we know exactly when to integrate it, how to pair it with other modalities (e.g., laser, manual therapy, or ESWT), and why it’s necessary to drive deeper systemic reset at this stage.
At this critical point, EMTT helps reboot stalled repair systems by stimulating mitochondrial energy production, rebalancing cellular ion channels, and reactivating tissue regeneration pathways that were previously dormant or suppressed by chronic inflammation or nerve sensitization.
As we progress toward functional loading and performance restoration, EMTT continues to support neurochemical recalibration, pain signal modulation, and muscular responsiveness, ensuring sustainable, pain-free movement and dynamic load tolerance.
Unlike short-term pain-masking modalities, EMTT targets root-level dysfunctions, helping restore balance across multiple systems. This makes it a perfect match for the S.H.I.V.A. Method™’s regenerative, whole-system, and non-maintenance-based philosophy of care.
EMTT is an excellent option for individuals seeking a non-invasive, drug-free approach to healing and recovery. Ideal candidates include:
Those with chronic musculoskeletal pain that hasn’t responded to standard physical therapy or medication.
Athletes and active individuals recovering from overuse injuries, tendon irritation, or joint stress.
Post-surgical patients who want to speed up soft tissue, tendon, or bone healing.
Adults with degenerative conditions, such as osteoarthritis, disc wear, or spinal stiffness.
Individuals hoping to avoid injections, painkillers, or surgery as part of their recovery plan.
Because EMTT is painless, well-tolerated, and non-pharmacological, it’s a great fit for a wide range of people, including older adults, those with chronic conditions, and patients with orthopedic hardware (pending clinical screening and safety review).
Electromagnetic Transduction Therapy (EMTT) sessions are quick, comfortable, and seamlessly fit into your daily routine. Here’s what you can expect:
Each session typically lasts 10 to 20 minutes, depending on the body region and condition being treated.
Typically administered 1 to 2 times per week, allowing your body ample time to respond and repair between sessions while still maintaining therapeutic momentum.
Most patients undergo a course of 6 to 8 sessions . Chronic, long-standing, or more complex cases may require a longer or staged plan to achieve lasting results.
The treatment is completely painless. You may feel a gentle, rhythmic tapping or pulsing sensation in the treatment area as the magnetic field reaches underlying tissues.
EMTT is applied over clothing; no need to remove garments or apply messy gels. You’ll simply relax in a comfortable position as the applicator is positioned over the target area.
There is no downtime. You can immediately return to your normal daily activities, including exercise, work, or sports, with no restrictions following treatment.
Many patients begin noticing improvements in pain, mobility, and overall function within just a few sessions, with cumulative benefits increasing over time.
No. EMTT operates at significantly higher energy (up to 150 mT) and frequency (>100,000 Hz) than typical PEMF devices (5–15 mT, <100 Hz), enabling deeper, clinically meaningful biological effects .
EMTT is backed by rigorous scientific research and clinical studies.
Prospective feasibility study (53 patients) showing significant pain reduction and functional improvement in chronic mid-portion Achilles tendinopathy treated with EMTT compared to heel-cushion control.
Case report demonstrating accelerated bone healing in a delayed-union calcaneus fracture using combined ESWT + EMTT.
Early data suggesting that ESWT + EMTT post-surgery can lead to faster pain reduction, earlier weight-bearing, and improved radiographic healing compared to matched controls.
Demonstrating EMTT’s ability to significantly increase osteoblast activity, upregulate osteogenic genes (e.g. COL1A1, ALPL, BGLAP), and enhance bone matrix mineralization — without compromising cell viability.
Data indicate that EMTT stimulates bone-forming cells, promotes matrix mineralization, and supports fracture healing and bone regeneration.
